Furthermore, SNRNP200 is implicated in the aggressiveness of prostate cancer tumors, highlighting its role in tumor pathology and suggesting its potential as a target for therapeutic intervention [19,42]. This evidence concerns the gene SNRNP200 and prostate carcinoma.